Scemblix (asciminib)
pCPA File Number:
23324
Negotiation Status:
Active Negotiation
Indication(s):
Adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
PC0405-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable